IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 11

Issue Published : 119

Article Submitted : 22189

Article Published : 8705

Total Authors : 22904

Total Reviewer : 820

Total Countries : 161

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A review on analytical method development and validation of remogliflozin in bulk and combination dosage forms.
Authors Name: Shital Bade , Chaitali Chavan , Aniket Khaire , Vaishnavi Madure , Vikram Veer
Download E-Certificate: Download
Author Reg. ID:
IJRTI_202497
Published Paper Id: IJRTI2504165
Published In: Volume 10 Issue 4, April-2025
DOI:
Abstract: — SGLT is newly developed class of antidiabetic medicine also called as gliflozins. Type II diabetes mellitus is treated with SGLT-2 class inhibitors, such as remogliflozin and ertugliflozin. This study focuses on the most recent chromatographic and spectrophotometric methods for determining remogliflozin in pharmaceutical dosage forms and in bulk. And RP-HPLC, UV, RP-UPLC, and LC-MS techniques are used to estimate Remogliflozin. Numerous articles that provide analytical techniques and method validation for the same have already been published. The current review summarizes the most widely used techniques, including liquid chromatographic and spectrometric methods. HPLC methods for Remogliflozin alone and in combination include parameters like matrix, stationary phase, mobile phase composition detection wavelength, etc., as well as spectrometric methods for Remogliflozin alone and in combination include parameters like λ max, solvent, matrix, etc.
Keywords: Remogliflozin etabonate (REM), Metformin (MET), Vildagliptin (VDG), RP-HPLC, UV, HPTLC, Diabetes Mellitus.
Cite Article: "A review on analytical method development and validation of remogliflozin in bulk and combination dosage forms. ", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.10, Issue 4, page no.b535-b539, April-2025, Available :http://www.ijrti.org/papers/IJRTI2504165.pdf
Downloads: 000501
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2504165
Registration ID:202497
Published In: Volume 10 Issue 4, April-2025
DOI (Digital Object Identifier):
Page No: b535-b539
Country: Pune, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2504165
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2504165
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner